InvestSMART

Visionflex Group Limited (ASX:VFX)

ALERT: Price-sensitive ASX Announcement for VFX
Current share price for VFX : $0.061 0.006 (10.91%)+
Release
13 Jul 2026 9:04AM
Price at Release
$0.055
Full Release
download
Summary
Visionflex Group Limited reported a successful Q4 FY26 with positive cash flow and strategic advancements. The company achieved a 3% increase in quarterly cash receipts and 8% for the fiscal year, despite a decline in revenue due to deferred hardware deliveries. The introduction of their unattended access capability, enabling remote clinician-led consultations, marks a significant innovation, with the Royal Flying Doctor Service SA/NT as the first adopter. New contracts were secured, including with NSW Health. Operating and administration costs saw a notable reduction, contributing to the positive cash flow. As of June 30, 2026, Visionflex held $1.6 million in cash, with plans to continue cost discipline and pursue expanded enterprise opportunities in FY27.
Key Points
  • Visionflex achieved positive operating cash flow in Q4 and 2H FY26.
  • Cash receipts increased by 3% for Q4 FY26 and 8% for FY26.
  • Revenue decreased due to deferred hardware deliveries to Q1 FY27.
  • Annual Recurring Revenue reached $1.95 million, up 3% from the previous year.
  • New contracts secured include NSW Health and RFDS SA/NT.
  • Introduced unattended access capability, allowing clinician-led consultations remotely.
  • Royal Flying Doctor Service SA/NT is the first customer for the new product.
  • Operating and administration payments reduced by 28% in the second half of FY26.
  • Visionflex held $1.6 million in cash at the end of Q4 FY26.
  • Outlook includes maintaining cost discipline and expanding enterprise opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.